Resolving Oral Bacteria Interactions with a High-Throughput Low-Cost Single-Cell Transcriptomics Approach
Project Number5R21DE032890-02
Contact PI/Project LeaderMCLEAN, JEFFREY SCOTT Other PIs
Awardee OrganizationUNIVERSITY OF WASHINGTON
Description
Abstract Text
1 Abstract
2 Interactions among the microbiota within human microbiome are what define the community function during
3 healthy homeostasis and changes in these relationships can result in increased virulence leading to disease.
4 Bacteria from different species in the oral cavity make up the diverse plaque biofilms and are well known to
5 recognize and bind each other when grown together or artificially mixed (aggregation). Many studies rely on this
6 model to determine how cell-cell interactions affect each member. However, a major limitation to understanding
7 how direct binding between microbes may regulate expression within a simple dual bacteria:bacteria interaction
8 is the fact that there are mixed cell states within the co-culture. In reality, there is not a controlled 1:1 relationship,
9 and not all cells within the culture are directly bound to another cell. Many cells will remain free but still influenced
10 by soluble metabolites and signals in the shared media environment. When bulk transcriptomics are applied to
11 measure the gene expression of such mixed cultures, the average expression of all the cell states together
12 generates noise that interferes with the true signal of interest – what is occurring in specific biological states,
13 such as cells that are attached to each other. This results in a high probability that a true positive will be
14 missed and the inability to confidently attribute observed changes to the cells of interest. Ultimately this problem
15 represents a universal issue in all microbiology that has largely been ignored to date mainly due to the
16 technological limitations of physically capturing only the cells of interest as well as the biological limitation of low
17 bacterial mRNA content. Here we propose to leverage a recent breakthrough in single-cell transcriptomics
18 (scRNAseq) that has been developed for prokaryotes and successfully applied to monocultures and artificially
19 mixed non-interacting bacteria (MPI Kuchina et al., Science 2021), designated MicroSPLiT (microbial split-pool
20 ligation transcriptomics). MicroSPLiT was achieved through overcoming major challenges specific to bacteria,
21 such as their low mRNA content, diversity in cell size, and cell wall architecture. This technique is designed to
22 be high throughput, profiling tens of thousands of cells in a single experiment, low-cost, and importantly, an
23 approach achievable by any lab with only basic laboratory equipment. The goal of this study is to leverage and
24 expand upon this very recent, highly innovative breakthrough to: 1) Overcome a major universal problem in
25 microbiology by developing a comprehensive approach to determine true cell-cell binding interactions at the
26 single-cell level, and 2) apply this technique to gain insight into several important interactions between oral
27 microbial species including known periopathogens and those between recently discovered ultrasmall, reduced
28 genome parasitic oral bacteria and their bacterial host. Overall, the outcomes of this project are expected to
29 directly advance our understanding of the regulation of genes between physically interacting microbiota and
30 develop a protocol for the research community to be able to utilize this new widely accessible approach.
31
Public Health Relevance Statement
Narrative
Understanding how microbes may regulate the expression of virulence factors when directly
encountering another cell type requires single-cell resolution however there are many technical
and biological barriers to achieving this for bacteria. Here we propose to leverage a recent
breakthrough in single-cell transcriptomics (scRNAseq) that has been developed for prokaryotes
designated MicroSPLiT to study these cell-cell interactions.
National Institute of Dental and Craniofacial Research
CFDA Code
121
DUNS Number
605799469
UEI
HD1WMN6945W6
Project Start Date
01-March-2023
Project End Date
28-February-2026
Budget Start Date
01-March-2024
Budget End Date
28-February-2026
Project Funding Information for 2024
Total Funding
$213,847
Direct Costs
$177,723
Indirect Costs
$36,124
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Dental and Craniofacial Research
$213,847
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R21DE032890-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R21DE032890-02
Patents
No Patents information available for 5R21DE032890-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R21DE032890-02
Clinical Studies
No Clinical Studies information available for 5R21DE032890-02
News and More
Related News Releases
No news release information available for 5R21DE032890-02
History
No Historical information available for 5R21DE032890-02
Similar Projects
No Similar Projects information available for 5R21DE032890-02